IDSA offers two e-mail services to help members stay informed of updates from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). Content includes a range of topics, including new drug approvals and warnings. Recent alerts have included:

• FDA Approves the First Vaccine to Prevent Meningococcal Disease in Infants and Toddlers* (04/22/2011)

• FDA Warns Companies to Stop Making MRSA Claims for Over-the-Counter Products (04/21/2011)

IDSA members can sign up for these services online. (You must be logged in to have access to this link.)

*Note: This vaccine does not prevent infection with serogroup B Neisseria meningitidis, which is the most common serogroup in infants.

Is Your Facility Experiencing Antibiotic Shortages?
Report these to FDA and IDSA.

How useful is this article?

< Previous Article | Next Article >